Itch
40
6
7
23
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.0%
2 terminated out of 40 trials
92.0%
+5.5% vs benchmark
5%
2 trials in Phase 3/4
9%
2 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (40)
Establishment of a Patient Library in Patients With Pruritus Sine Materia
Efficacy and Safety of HA35 Gel for Ultra-Rapid Skin Pruritus Relief
Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
Mechanisms Underlying the Nocibo Effect of Contagious Itch. in Both Histaminergic and Nonhistaminergic Itch
Mechanisms Underlying the Placebo Effect in Both Histaminergic and Non-histaminergic Itch
Topographical Distribution of Itch and Pain Receptors
Role of Interleukin-13 Pathways on Pain and Itch Sensitivity
Identification of the Mechanism of Non-histaminergic Itch Inducing Epigenetic Changes
Reducing Itch With Hypnosis and Virtual Reality
Effect of Ketamine, Amitriptyline and Their Combination on Itch
Pregabalin Treatment for RDEB Pain and Itch
The Effects of Performing a Motor Imagery Task on Cortical Excitability During Acute Experimental Muscle Pain and Acute Itch
Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch
Investigation of Corticospinal Excitability Aspects of Itch and Pain
The Effect of Cooling With a Bed Topper and Linen on Itch in Clinical Routine
Efficacy and Safety of Tofacitinib in Patients With Prurigo Nodularis
Psychogenic and Neurogenic Components in Patients With Psychogenic or Neuropathic Pruritus
Characterization of Bovine Adrenal Medulla as a New Surrogate Model of Non-histaminergic Itch
Characterization of Bovine Adrenal Medulla as a Model of Non-histaminergic Itch
Testing Protocol to Efficiently Induce Itch